Healthcare Industry News: CRBSI
News Release - April 24, 2007
Iapyx(TM) Medical Introduces Stable-Line Family of Catheter Stabilization Devices Designed to Minimize Complications and InfectionsSAN DIEGO--(HSMN NewsFeed)--Iapyx(TM) Medical, a developer of innovative single-use medical devices, introduced its Stable-LineŽ family of catheter stabilization products designed to minimize the risk of catheter-related bloodstream and urinary tract infections, two of the three most common hospital-acquired infections. With the launch of Stable-LineŽ Arterial and Stable-LineŽ Foley catheter stabilization devices, Iapyx Medical aims to combat the epidemic of hospital-acquired infections and improve patient care and clinician safety.
The Stable-LineŽ Arterial catheter stabilization device is designed to prevent inadvertent movement and dislodgment of arterial lines. Suture securement, the traditional means of arterial line securement, increases patients' risks of developing catheter-related bloodstream infections (CRBSI), which pose a significant mortality risk. Suture securement also puts healthcare workers at risk for needlestick injuries, which expose them to blood-borne pathogens including Hepatitis B, Hepatitis C, and HIV. The Stable-LineŽ Arterial device mitigates these risks while addressing OSHA's recommendation for sutureless securement and meeting Infusion Nurses Society (INS) standards as a manufactured stabilization device. Without the use of invasive sutures or conventional strips of tape, the Stable-LineŽ Arterial catheter stabilization device firmly grips the extension set to immobilize the catheter while permitting visual inspection and monitoring of the insertion site.
"We know that catheter-related bloodstream infections are one of the most common and deadly hospital-acquired infections, and they cost hospitals between $296 million to $2.3 billion annually according to the CDC," said Chris Whelan, Vice President of Marketing at Iapyx Medical. "Iapyx Medical's Stable-Line family of products provides a cost effective way to minimize patient and clinician health risks with simple, effective securement devices."
Iapyx Medical also introduced the Stable-LineŽ Foley catheter stabilization device, which addresses the infection risks, complications and discomfort associated with indwelling Foley (urinary) catheters. To secure Foley catheters, most critical care clinicians use tape and leg-straps, which are not only ineffective in securing the catheters but are inadequate defenses against urethral irritation, meatal erosion and accidental dislodgement. The Stable-LineŽ Foley catheter stabilization device minimizes these complications by securing the catheter and reducing inadvertent movement. The device, designed with a releasable and rotating dead-bolt style locking mechanism, allows for patient movement while maintaining skin integrity.
Iapyx Medical's products have been successfully adopted by hospitals nationwide, including Loma Linda University Medical Center. "Loma Linda University Medical Center routinely uses non-invasive catheter stabilization devices to reduce the frequency of insertion site trauma and catheter-related infections," said Pam Bracker, Director of Clinical Materials. "By effectively stabilizing Foley and vascular access devices, we lower the patient's risk of developing urinary tract and bloodstream infections -- two of the most common hospital-acquired infections in the US."
For more details on the Stable-LineŽ Arterial and Stable-LineŽ Foley, please go to: www.iapyx.com.
About Iapyx(TM) Medical
Based in San Diego, Iapyx(TM) Medical develops and manufactures single-use medical devices designed to combat the epidemic of hospital-acquired infections while improving patient care and healthcare worker safety. Today, Iapyx markets two product families that protect both patients and clinicians. The Iso-Line(TM) family uses isolation techniques to prevent exposure of patients and clinicians to dangerous pathogens and contaminated devices. The Stable-LineŽ family of catheter stabilization devices is designed to minimize the risk of site infections, bloodstream and urinary tract infections, and other catheter-related complications.
For more information, call Iapyx Medical at (888) 575-6341 or visit www.iapyx.com.
Source: Iapyx Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.